research Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia
Hair loss causes stress and affects mental health; treatment and support needed.
Search
for
Sort by
Research
120-150 / 1000+ results 
research A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
Common skin conditions can greatly affect a person's mental health and social life.
research Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital.
Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.
research Comprehensive Evaluation of Androgenetic Alopecia: Demographic Characteristics, Psychosocial Impact, and the Role of Social Media in Treatment Choices
Social media doesn't significantly influence treatment choices for hair loss, but better education on options is needed.
research A Comprehensive Review on Alopecia Areata and its Pathophysiology, Diagnosis, Treatment, and Psychosocial Impact
Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.
research A Comprehensive Review on Alopecia Areata and its Pathophysiology, Diagnosis, Treatment, and Psychosocial Impact
Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.
research A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
PCOS skin symptoms need personalized treatment and psychological support to improve quality of life.
research Psychosocial Aspects of Skin Conditions and Diseases
Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.
research PERCEPÇÃO PSICOSSOCIAL DE PACIENTES COM ALOPECIA ANDROGENÉTICA FEMININA / PSYCHOSOCIAL PERCEPTION OF PATIENTS WITH FEMALE ANDROGENETIC ALOPECIA
Female hair loss causes emotional distress and needs holistic treatment.
research Psychosocial aspects of androgenetic alopecia
Hair loss can cause significant social and emotional issues, especially for women and young men.
research Educating for Empathy: Impact of a Targeted Alopecia Areata Curriculum on Middle School Students
The program improved students' understanding and acceptance of alopecia areata.
research CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
The EQ-5D does not fully capture the impact of alopecia areata on quality of life.
research O PROCESSO DE ENFERMAGEM NO TRANSPLANTE CAPILAR: O IMPACTO DOS CUIDADOS PERIOPERATÓRIOS
Nursing care is crucial for safe and effective hair transplants.
research Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.
research Anagen effluvium
Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.
research Alopecia With Endocrine Therapies in Patients With Cancer
Endocrine therapies for cancer significantly increase the risk of hair loss.
research Quality of life in children and adolescents with alopecia areata—A systematic review
Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.
research What′s new in cicatricial alopecia?
New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.
research Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.
Acne in adult women is common and requires thorough evaluation and treatment due to its impact on self-esteem.
research Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study
Stress can trigger or worsen alopecia areata.
research II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.
research Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.
research To Feel Again: The Strength of a Support Community
Connecting with supportive communities is crucial for healthcare professionals to address their own health and well-being.
research Alopecia Areata: The Clinician and Patient Voice
Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.
research Awareness, knowledge, and perceptions of alopecia among UK postgraduate students: a cross-sectional study
UK postgraduate health students have limited understanding of alopecia, with many misconceptions, highlighting the need for better awareness.
research ANDROGENETIC ALOPECIA
New treatments for androgenetic alopecia are emerging, improving hair loss management.
research ANDROGENETIC ALOPECIA
New treatments for androgenetic alopecia are emerging, improving options for managing hair loss.
research Alopecia areata ja psykososiaalinen hyvinvointi: Vaikutukset naisen minäkuvaan
Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.
research Hair
Alopecia areata causes significant emotional and social challenges, especially with more hair loss.
research Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
Alopecia areata in Brazil causes significant psychosocial impacts, with limited access to advanced treatments, especially in public healthcare.